Literature DB >> 18596380

Low-intensity alternating electric fields: a potentially safe and effective treatment of cancer?

Thies Schroeder, Benjamin L Viglianti, Mark W Dewhirst.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18596380      PMCID： PMC2776831          DOI： 10.1159/000140601

Source DB:  PubMed          Journal:  Onkologie        ISSN： 0378-584X


× No keyword cloud information.
  8 in total

Review 1.  Angiogenesis inhibitors generated by tumors.

Authors:  J Folkman
Journal:  Mol Med       Date:  1995-01       Impact factor: 6.354

2.  A strategy to discover circulating angiogenesis inhibitors generated by human tumors.

Authors:  C Chen; S Parangi; M J Tolentino; J Folkman
Journal:  Cancer Res       Date:  1995-10-01       Impact factor: 12.701

Review 3.  Chemoradiotherapy in malignant glioma: standard of care and future directions.

Authors:  Roger Stupp; Monika E Hegi; Mark R Gilbert; Arnab Chakravarti
Journal:  J Clin Oncol       Date:  2007-09-10       Impact factor: 44.544

4.  A pilot study with very low-intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors.

Authors:  Marc Salzberg; Eilon Kirson; Yoram Palti; Christoph Rochlitz
Journal:  Onkologie       Date:  2008-06-24

5.  Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors.

Authors:  Eilon D Kirson; Vladimír Dbalý; Frantisek Tovarys; Josef Vymazal; Jean F Soustiel; Aviran Itzhaki; Daniel Mordechovich; Shirley Steinberg-Shapira; Zoya Gurvich; Rosa Schneiderman; Yoram Wasserman; Marc Salzberg; Bernhard Ryffel; Dorit Goldsher; Erez Dekel; Yoram Palti
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-05       Impact factor: 11.205

6.  Disruption of cancer cell replication by alternating electric fields.

Authors:  Eilon D Kirson; Zoya Gurvich; Rosa Schneiderman; Erez Dekel; Aviran Itzhaki; Yoram Wasserman; Rachel Schatzberger; Yoram Palti
Journal:  Cancer Res       Date:  2004-05-01       Impact factor: 12.701

7.  Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma.

Authors:  M S O'Reilly; L Holmgren; Y Shing; C Chen; R A Rosenthal; M Moses; W S Lane; Y Cao; E H Sage; J Folkman
Journal:  Cell       Date:  1994-10-21       Impact factor: 41.582
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.